AmeriCann's Cannabis Center In MA Will Be One Of Country's Largest

Cannabis facility specialist AmeriCann is preparing to develop the first phase of the Massachusetts Medical Cannabis Center (MMCC), which it plans as one of the largest cannabis cultivation facilities in the nation.

“The legalization of cannabis for all adults in Massachusetts significantly expands the need for the infrastructure to serve both patients and consumers," AmeriCann CEO Tim Keogh said. Nearly 1M SF has been approved for development at his firm's site.

Courtesy of Campenelli Construction

AmeriCann acquired 53 acres in Freetown for the development earlier this year, and has tapped Campanelli Construction to build the facility. The first phase of the greenhouse complex will include two buildings of 130k SF and 30k SF, and the second phase is permitted for 800k SF or more, based on demand.

It's part of a larger push by the company to develop facilities nationwide. AmeriCann recently completed a $2M all-equity financing that will be used in part for the MMCC, but also to pursue opportunities in California, Pennsylvania, Florida and other states.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

BioMed Sells Cambridge Office At A Loss: The Boston Deal Sheet

Big Money Bets On SoCal Industrial As 2 Portfolio Sales Top $3B

2.7M SF Campus Trades In Houston's Largest Industrial Sale

Former Randolph Event Venue Planned For 200-Room Hotel, Theater

Gaming & Leisure Stays Bullish On Bally's Casino Project Despite Delays

Brookfield, CPP Complete $5.2B REIT Buyout, Pick Up U.S. Logistics Assets

Taiwan Semiconductor Manufacturing Co. Could Expand In North Texas

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

140-Acre Attleboro Golf Course Hits Market, Pitched For Redevelopment

Prologis To Develop 3.8M SF Industrial Park On Former Casino Site

Foundry Robotics Leaves San Francisco For New East Bay HQ

Alexandria Sells Stakes In Megacampuses To Weather Life Sciences Downturn